Safety and feasibility of integrating yttrium-90 radioembolization with capecitabine-temozolomide for grade 2 liver-dominant metastatic neuroendocrine tumors - Soulen, M C; van Houten, D; Teitelbaum, U R; Damjanov, N; Cengel, K A; Metz, D C (Pancreas, 2018)